The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome.
The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with the non-constipating irritable bowel syndrome.